BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38629420)

  • 1. A randomised multicentre study of angiography- versus physiologyguided percutaneous coronary intervention in patients with coronary artery disease undergoing TAVI: design and rationale of the FAITAVI trial.
    Ribichini F; Pesarini G; Fabris T; Lunardi M; Barbierato M; D'Amico G; Zanchettin C; Gregori D; Piva T; Nicolini E; Gandolfo C; Fineschi M; Petronio AS; Berti S; Caprioglio F; Saia F; Sclafani R; Esposito G; D'Ascenzo F; Tarantini G
    EuroIntervention; 2024 Apr; 20(8):e504-e510. PubMed ID: 38629420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale.
    Kedhi E; Rroku A; Hermanides RS; Dambrink JH; Singh S; Berg JT; van Ginkel DJ; Hudec M; Amoroso G; Amat-Santos IJ; Andreas M; Teles RC; Bonnet G; Van Belle E; Conradi L; van Garsse L; Wojakowski W; Voudris V; Sacha J; Cervinka P; Lipsic E; Somi S; Nombela-Franco L; Postma S; Piayda K; De Luca G; Malinofski K; Modine T
    Am Heart J; 2024 Apr; 270():86-94. PubMed ID: 38309610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third nordic aortic valve intervention trial - NOTION-3.
    Sabbah M; Veien K; Niemela M; Freeman P; Linder R; Ioanes D; Terkelsen CJ; Kajander OA; Koul S; Savontaus M; Karjalainen P; Erglis A; Minkkinen M; Jørgensen T; Sondergaard L; De Backer O; Engstrøm T; Lønborg J
    Am Heart J; 2023 Jan; 255():39-51. PubMed ID: 36220354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI.
    Scarsini R; Pesarini G; Lunardi M; Piccoli A; Zanetti C; Cantone R; Bellamoli M; Ferrero V; Gottin L; Faggian G; Ribichini F
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):355-359. PubMed ID: 29113864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Lunardi M; Scarsini R; Venturi G; Pesarini G; Pighi M; Gratta A; Gottin L; Barbierato M; Caprioglio F; Piccoli A; Ferrero V; Ribichini F
    J Am Heart Assoc; 2019 Nov; 8(22):e012618. PubMed ID: 31718439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation: Influence of Pressure Overload on the Evaluation of Lesions Severity.
    Pesarini G; Scarsini R; Zivelonghi C; Piccoli A; Gambaro A; Gottin L; Rossi A; Ferrero V; Vassanelli C; Ribichini F
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Sejr-Hansen M; Christiansen EH; Ahmad Y; Vendrik J; Westra J; Holm NR; Thim T; Seligman H; Hall K; Sen S; Terkelsen CJ; Eftekhari A
    Catheter Cardiovasc Interv; 2022 Jan; 99(1):68-73. PubMed ID: 33533535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Scarsini R; Pesarini G; Zivelonghi C; Piccoli A; Ferrero V; Lunardi M; Gottin L; Zanetti C; Faggian G; Ribichini F
    EuroIntervention; 2018 Jan; 13(13):1512-1519. PubMed ID: 28846545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional flow reserve in patients with coronary artery disease undergoing TAVI: a prospective analysis.
    Stundl A; Shamekhi J; Bernhardt S; Starke M; Al-Kassou B; Weber M; Sedaghat A; Treede H; Grube E; Nickenig G; Werner N; Sinning JM
    Clin Res Cardiol; 2020 Jun; 109(6):746-754. PubMed ID: 31679046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of machine-learning-based coronary computed tomography angiography-derived fractional flow reserve on decision-making in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Brandt V; Schoepf UJ; Aquino GJ; Bekeredjian R; Varga-Szemes A; Emrich T; Bayer RR; Schwarz F; Kroencke TJ; Tesche C; Decker JA
    Eur Radiol; 2022 Sep; 32(9):6008-6016. PubMed ID: 35359166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete Functional Revascularization Is Associated With Adverse Clinical Outcomes After Transcatheter Aortic Valve Implantation.
    Scarsini R; Venturi G; Pighi M; Lunardi M; Kotronias R; Del Sole PA; Rubino F; Tavella D; Pesarini G; Banning A; Ribichini F
    Cardiovasc Revasc Med; 2022 Sep; 42():47-52. PubMed ID: 35272945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study.
    Barbanti M; Buccheri S; Capodanno D; D'Errigo P; Ranucci M; Rosato S; Santoro G; Fusco D; Tamburino C; Biancari F; Seccareccia F;
    Int J Cardiol; 2018 Nov; 270():102-106. PubMed ID: 29903519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Ullah W; Sarvepalli D; Kumar A; Zahid S; Saleem S; Muhammadzai HZU; Khattak F; Block PC; Jaber WA; Shishehbor MH; Filby SJ; Devireddy C
    Catheter Cardiovasc Interv; 2023 Nov; 102(5):946-957. PubMed ID: 37698396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided intervention strategy for clinical outcomes in patients with coronary artery disease: a randomised controlled trial (FLAVOUR II).
    Zhang J; Hu X; Jiang J; Lu D; Guo L; Peng X; Pan Y; He W; Li J; Zhou H; Huang J; Jiang F; Pu J; Cheng Z; Yang B; Ma J; Chen P; Liu Q; Song D; Lu L; Li S; Fan Y; Meng Z; Tang L; Shin ES; Tu S; Koo BK; Wang J
    BMJ Open; 2023 Dec; 13(12):e074349. PubMed ID: 38072492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Wenaweser P; Pilgrim T; Guerios E; Stortecky S; Huber C; Khattab AA; Kadner A; Buellesfeld L; Gloekler S; Meier B; Carrel T; Windecker S
    EuroIntervention; 2011 Sep; 7(5):541-8. PubMed ID: 21930453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI.
    Fezzi S; Ding D; Scarsini R; Huang J; Del Sole PA; Zhao Q; Pesarini G; Simpkin A; Wijns W; Ribichini F; Tu S
    Circ Cardiovasc Interv; 2023 Oct; 16(10):e013185. PubMed ID: 37712285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation.
    Rheude T; Costa G; Ribichini FL; Pilgrim T; Amat Santos IJ; De Backer O; Kim WK; Ribeiro HB; Saia F; Bunc M; Tchétché D; Garot P; Mylotte D; Burzotta F; Watanabe Y; Bedogni F; Tesorio T; Tocci M; Franzone A; Valvo R; Savontaus M; Wienemann H; Porto I; Gandolfo C; Iadanza A; Bortone AS; Mach M; Latib A; Biasco L; Taramasso M; Zimarino M; Tomii D; Nuyens P; Sondergaard L; Camara SF; Palmerini T; Orzalkiewicz M; Steblovnik K; Degrelle B; Gautier A; Del Sole PA; Mainardi A; Pighi M; Lunardi M; Kawashima H; Criscione E; Cesario V; Biancari F; Zanin F; Esposito G; Adam M; Grube E; Baldus S; De Marzo V; Piredda E; Cannata S; Iacovelli F; Andreas M; Frittitta V; Dipietro E; Reddavid C; Strazzieri O; Motta S; Angellotti D; Sgroi C; Xhepa E; Kargoli F; Tamburino C; Joner M; Barbanti M
    EuroIntervention; 2023 Sep; 19(7):589-599. PubMed ID: 37436190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation.
    Zivelonghi C; Pesarini G; Scarsini R; Lunardi M; Piccoli A; Ferrero V; Gottin L; Vassanelli C; Ribichini F
    Am J Cardiol; 2017 Aug; 120(4):625-631. PubMed ID: 27964903
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.